When the patent is added, the major pieces of the Myovad will be in place. There may be other "pieces" that are needed, but they will not prevent the device from moving forward.
Of course, this assumes that the vote FOR an increase in the amount of shares passes. If it doesn't, I suspect BIPH will be in big, big trouble. Trying to figure another way to turn things around will increase the cash burn, as well as encourage more financing, spiraling BIPH into near certain death. This type of strategy is more risky than dilution.
Again, I'd rather have 800 MIL shares worth SOMETHING, than 243 MIL worth NOTHING.
Most long time investors, although upset about the dilution, would probably agree. When we look at the long term picture without the extra shares, it seems exceptionally bleak.
If anyone believes in BIPH and is upset about the dilution, then buy more shares, cost averging down. That is, of course, if you want to put more money into the stock. At 1.5 cents or less, I'm sure someone could add enough shares to cost average down and take a nice position for the future.
If anyone is not sure, then don't buy more shares or sell the ones you have. But don't penalize the rest of us by voting AGAINST if we're still holding and hoping.
I've lost substantially on paper, as I've not sold a single share. But, even if I had realized an actual loss, I would still vote FOR. But that's just me.
All the best,
Tet
News 
Market Data 
Discover 
